In a recent metadata analysis analyzing 54 human studies for bloodborne inflammatory and redox biomarkers of PTSD, only C-reactive protein, interleukin 6, and tumor necrosis factor reached statistical significance in patients with PTSD compared with healthy controls (Peruzzolo et al., 2022). This evidence concerns the gene CRP and post-traumatic stress disorder.